Cited by 690Nicotinic Acetylcholine Receptors StudySchizophrenia research and treatmentNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.

Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia

Freedman, Robert, Hall, Michael, Adler, Lawrence E., Leonard, Sherry·1995·Biological Psychiatry

DOI 10.1016/0006-3223(94)00252-x

Open this paper in CoChat — free account

Abstract

This study tests the hypothesis that nicotinic cholinergic receptors, including those sensitive to the antagonist alpha-bungarotoxin, are decreased in the hippocampus of schizophrenics. The hypothesis is derived from the finding that alpha-bungarotoxin causes a defect in the inhibitory gating of auditory-evoked potentials in laboratory animals that resembles a defect in auditory sensory gating observed in schizophrenics. Nicotine transiently normalizes this psychophysiological deficit in schizophrenic patients. Postmortem brain tissue was obtained from eight schizophrenic and eight age-matched nonschizophrenic subjects. Sections of the hippocampus were labeled with [125I alpha-bungarotoxin and imagined by autoradiography. Binding of the nicotinic agonist [3H]-cytisine was determined in tissue homogenates. alpha-Bungarotoxin labeled a population of putative interneurons in the hippocampus, primarily in the dentate gyrus and the CA3 region of Ammon's horn. This labeling was significantly decreased in the tissue from the schizophrenic patients, with seven or eight patients below the range of the nonschizophrenic subjects. There was also a significant decrease in the binding of cytisine. The results were not related to generalized hippocampal cell loss, drug exposure at time of death, or smoking history. This initial study suggests that schizophrenic patients have fewer nicotinic receptors in the hippocampus, a condition which may lead to failure of cholinergic activation of inhibitory interneurons, manifest clinically as decreased gating of response to sensory stimulation.

Integrity signals

Registry

Crossref · 10.1016/0006-3223(94)00252-x

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Progress in experimental personality research
Maher, W. B., & Maher, B. A. (1964) · Academic Press eBooks · Cited by 2,347
Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium
Séguéla, P., Wadiche, J. I., Dineley‐Miller, K., Dani, J., & Jw, P. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471
Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia.
Adler, L. E., Pachtman, E., Franks, R. D., Pecevich, M., Waldo, M. C., & Freedman, R. (1982) · PubMed · Cited by 896
Self-citation
Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective Patients
Benes, F. M. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810350036005 · Cited by 891
Basal Ganglia and Limbic System Pathology in Schizophrenia: A Morphometric Study of Brain Volume and Shrinkage
Bogerts, B. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790310046006 · Cited by 880
A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880
Cigarette smoking: implications for psychiatric illness
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.546 · Cited by 723
Normalization of auditory physiology by cigarette smoking in schizophrenic patients
Adler, L. E., Hoffer, L., Wiser, A., & Freedman, R. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1856 · Cited by 679
Self-citation
Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects
GOFF, D. C., Henderson, D. C., & Amico, E. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1189 · Cited by 576

Show all 55 references

Research works printed but not linked: 3

Daviss, 1993, Calbindin- and calretinin-immunoreactive local circuit neurons are increased in density in the prefrontal cortex of schizophrenic subjects, Neurosci Abstracts, 19, 201
Goff, 1980, Neural origins of long latency evoked potentials recorded from the depth and from the cortical surface of the brain in man, Prog Clin Neurophysiol, 7, 126
Klein, 1991, On the influence of smoking upon smooth pursuit eye movements of schizophrenics and normal controls, J Psychophysiology, 5, 361

Sorted by citations

Items 101–200 of 690

Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampus
Alkondon, M., Pereira, E. F. R., Almeida, L. E. F., Randall, W. R., & Albuquerque, E. X. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00156-8 · Cited by 129
NIMH genetics initiative millennium schizophrenia consortium: Linkage analysis of African-American pedigrees
Kaufmann, C. A., Suarez, B. K., Malaspina, D., Pepple, J. R., Švrakić, D. M., Markel, P. D., Meyer, J. M., Zambuto, C. T., Schmitt, K., Matise, T. C., et al. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980710)81:4 · Cited by 266
Self-citation
Muscarinic and nicotinic receptor modulation of object and spatial -back working memory in humans
GREEN, A., Ellis, K. A., Ellis, J. R., Bartholomeusz, C., ILIC, S., Croft, R. J., LUANPHAN, K., & NATHAN, P. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.04.010 · Cited by 127
Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia
Kumari, V., Soni, W., & Sharma, T. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.286 · Cited by 126
Tropisetron improves deficits in auditory P50 suppression in schizophrenia
Koike, K., Hashimoto, K., Takai, N., Shimizu, E., Komatsu, N., Watanabe, H., Nakazato, M., Okamura, N., Stevens, K. E., Freedman, R., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.12.016 · Cited by 126
Self-citation
Sensory Gating Deficit Expressed by a Disturbed Suppression of the P50 Event-Related Potential in Patients With Alzheimer’s Disease
Jessen, F., Kucharski, C., Fries, T., Papassotiropoulos, A., Hoenig, K., Maier, W., & Heun, R. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1319 · Cited by 125
Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia
Young, J. W., & Geyer, M. A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.031 · Cited by 128
Function of Partially Duplicated Human α7 Nicotinic Receptor Subunit CHRFAM7A Gene
de Lucas‐Cerrillo, A. M., Maldifassi, M. C., Arnalich, F., Renart, J., Atienza, G., Serantes, R., Cruces, J., Sánchez‐Pacheco, A., Andrés‐Mateos, E., & Montiel, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.180067 · Cited by 123
Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia
Jubelt, L. E., Barr, R. S., GOFF, D. C., Logvinenko, T., Weiss, A. P., & Evins, A. E. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1133-8 · Cited by 121
The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function
Araud, T., Graw, S. L., Berger, R., Lee, M., Neveu, E., Bertrand, D., & Leonard, S. S. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.018 · Cited by 128
Self-citation
Genetics of Smoking and Schizophrenia
Leonard, S. S., Mexal, S., & Freedman, R. (2007) · Journal of Dual Diagnosis · doi:10.1300/j374v03n03_05 · Cited by 124
Self-citation
Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development
McCluskey, S. P., Plisson, C., Rabiner, E. A., & Howes, O. D. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04488-0 · Cited by 127
Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits
D’Souza, M. S., & Markou, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.044 · Cited by 121
Brain-specific Crmp2 deletion leads to neuronal development deficits and behavioural impairments in mice
Zhang, H., Kang, E., Wang, Y., Yang, C., Yu, H., Wang, Q., Chen, Z.-Y., Zhang, C., Christian, K. M., Song, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms11773 · Cited by 119
Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis
Roberts, E., Eden Evins, A., McNeill, A., & Robson, D. (2016) · Addiction · doi:10.1111/add.13236 · Cited by 119
Cholinergic connectivity: it's implications for psychiatric disorders
Scarr, E., Gibbons, A. S., Neo, J. H., Udawela, M., & Dean, B. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00055 · Cited by 124
Common aspects of the action of nicotine and other drugs of abuse
Picciotto, M. R. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00074-x · Cited by 117
Neuronal nicotinic acetylcholine receptors: from the gene to the disease
Weiland, S., Bertrand, D., & Leonard, S. S. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00199-6 · Cited by 117
Self-citation
Involvement of the cholinergic system in conditioning and perceptual memory
Robinson, L., Platt, B., & Riedel, G. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.055 · Cited by 115
Hippocampal volume and hippocampal neuron density, number and size in schizophrenia: a systematic review and meta-analysis of postmortem studies
Roeske, M. J., Konradi, C. L., Heckers, S., & Lewis, A. S. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0853-y · Cited by 117
Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia
Guillozet-Bongaarts, A. L., Hyde, T. M., Dalley, R. A., Hawrylycz, M., Henry, A. M., Hof, P. R., Hohmann, J. G., Jones, A. R., Kuan, C. L., Royall, J. J., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.30 · Cited by 113
RG3487, a Novel Nicotinic α7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents
Wallace, T., Callahan, P., Tehim, A., Bertrand, D., Tombaugh, G., Wang, S.-J., Xie, W., Rowe, W., Ong, V., Graham, E., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.171892 · Cited by 129
Alpha7 Nicotinic Acetylcholine Receptors Modulate Motivation to Self-Administer Nicotine: Implications for Smoking and Schizophrenia
Brunzell, D. H., & McIntosh, J. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.299 · Cited by 114
Cholinergic nicotinic receptors: Competitive ligands, allosteric modulators, and their potential applications
Romanelli, M. N., & Gualtieri, F. (2003) · Medicinal Research Reviews · doi:10.1002/med.10037 · Cited by 112
Human post-mortem striatal α4β2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome
Durany, N., Zöchling, R., Boissl, K. W., Paulus, W., Ransmayr, G. N., Tatschner, T., Danielczyk, W., Jellinger, K. A., Deckert, J., & Riederer, P. F. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01144-7 · Cited by 112
The role of cortical inhibition in the pathophysiology and treatment of schizophrenia
Daskalakis, Z. J., Fitzgerald, P. B., & Christensen, B. K. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.09.006 · Cited by 111
Nicotinic receptor desensitization and sensory gating deficits in schizophrenia
Griffith, J. M., O'Neill, J. E., Petty, F., Garver, D. L., Young, D. A., & Freedman, R. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00362-4 · Cited by 109
Self-citation
Theranostic Biomarkers for Schizophrenia
Perković, M. N., Erjavec, G. N., Štrac, D. Š., Uzun, S., Kozumplik, O., & Pivac, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040733 · Cited by 113
Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder
Smith, R. C., Lindenmayer, J., Davis, J. M., Cornwell, J. A., Noth, K., Gupta, S., Sershen, H. W., & Lajtha, Á. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.02.001 · Cited by 107
α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer’s Disease
Toyohara, J., & Hashimoto, K. (2010) · The Open Medicinal Chemistry Journal · doi:10.2174/1874104501004010037 · Cited by 109
Evidence of Association between Smoking and α7 Nicotinic Receptor Subunit Gene in Schizophrenia Patients
Luca, V. D., Wong, A. H. C., Müller, D. J., Wong, G. W. H., Tyndale, R. F., & Kennedy, J. L. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300466 · Cited by 107
Effects of an Alpha 7-Nicotinic Agonist on Default Network Activity in Schizophrenia
Tregellas, J. R., Tanabe, J., Rojas, D. C., Shatti, S., D, A. O. M., Johnson, L. L., Martín, L., Soti, F. S., Kem, W. R., Leonard, S. S., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.004 · Cited by 106
Self-citation
Nicotinic receptors and schizophrenia
Ripoll, N., Grall‐Bronnec, M., & Bourin, M. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125004060 · Cited by 106
A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia
Postma, P., Gray, J. A., Sharma, T., Geyer, M. A., Mehrotra, R., Das, M., Zachariah, E., Hines, M., Williams, S., & Kumari, V. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0307-5 · Cited by 105
Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models
Lyon, L., Saksida, L. M., & Bussey, T. J. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2536-5 · Cited by 107
The therapeutic promise of positive allosteric modulation of nicotinic receptors
Uteshev, V. V. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.072 · Cited by 105
Smoking Behaviour and Mental Health Disorders—Mutual Influences and Implications for Therapy
Minichino, A., Bersani, F. S., Calò, W. K., Spagnoli, F., Francesconi, M., Vicinanza, R., Chiaie, R. D., & Biondi, M. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10104790 · Cited by 110
Combined uridine and choline administration improves cognitive deficits in spontaneously hypertensive rats
de Bruin, N. M. W. J., Kiliaan, A. J., de Wilde, M. C., & Broersen, L. M. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00024-8 · Cited by 105
Phencyclidine-Induced Cognitive Deficits in Mice Are Improved by Subsequent Subchronic Administration of the Novel Selective α7 Nicotinic Receptor Agonist SSR180711
Hashimoto, K., Ishima, T., Fujita, Y., Matsuo, M., Kobashi, T., Takahagi, M., Tsukada, H., & Iyo, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.034 · Cited by 102
A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: Involvement of nicotinic receptor mechanisms
George, T. P., Termine, A., Sacco, K. A., Allen, T. M., Reutenauer, E. L., Vessicchio, J. C., & Duncan, E. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.05.022 · Cited by 103
Positive allosteric modulator of alpha 7 nicotinic-acetylcholine receptors, PNU-120596 augments the effects of donepezil on learning and memory in aged rodents and non-human primates
Callahan, P. M., Hutchings, E. J., Kille, N. J., Chapman, J., & Terry, A. V. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.10.019 · Cited by 102
Inside-out neuropharmacology of nicotinic drugs
Henderson, B. J., & Lester, H. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.022 · Cited by 109
The role of neurexins in schizophrenia and autistic spectrum disorder
Reichelt, A. C., Rodgers, R. J., & Clapcote, S. J. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.024 · Cited by 110
Pathological mutations of nicotinic receptors and nicotine-based therapies for brain disorders
Léna, C., & Changeux, J. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80088-8 · Cited by 101
Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia
Martin-Ruiz, C. M., Haroutunian, V. H., Long, P., Young, A. H., Davis, K. L., Perry, E. K., & Court, J. A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00348-2 · Cited by 100
Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
Hyde, T. M., & Crook, J. M. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(01)00101-6 · Cited by 97
Differential Regulation of α7 Nicotinic Receptor Gene (CHRNA7) Expression in Schizophrenic Smokers
Mexal, S., Berger, R., Logel, J., Ross, R. G., Freedman, R., & Leonard, S. S. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9233-4 · Cited by 101
Self-citation
Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]α‐bungarotoxin binding sites in the brain of Macaca mulatta
Han, Z., Zoli, M., Cardona, A., Bourgeois, J., Changeux, J., & Novère, N. G. L. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10659 · Cited by 102
Cholinesterase Inhibitors Ameliorate Behavioral Deficits Induced by MK-801 in Mice
Csernansky, J. G., Martin, M. V., Shah, R., Bertchume, A., Colvin, J., & Dong, H. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300761 · Cited by 99
Ion channels-related diseases.
Dworakowska, B., & Dołowy, K. (2000) · Acta Biochimica Polonica · doi:10.18388/abp.2000_3989 · Cited by 99
Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia
Walling, D. P., Marder, S. R., Kane, J. M., Fleischhacker, W. W., Keefe, R. S. E., Hosford, D. A., Dvergsten, C., Segreti, A. C., Beaver, J. S., Toler, S. M., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv072 · Cited by 98
Association of the 5′-upstream regulatory region of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia
Stephens, S. H., Logel, J., Barton, A., Franks, A. L., Finlay-Schultz, J., Short, M., Dickenson, J., James, B., Fingerlin, T. E., Wagner, B. D., et al. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2008.12.017 · Cited by 97
Self-citation
Molecular substrates of schizophrenia: homeostatic signaling to connectivity
Landek‐Salgado, M. A., Faust, T. E., & Sawa, A. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.141 · Cited by 95
α7 Nicotinic acetylcholine receptors and their role in cognition
Lendvai, B., Kassai, F., Szájli, Á., & Némethy, Z. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.11.003 · Cited by 99
Effect of R3487/MEM3454, a novel nicotinic alpha7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats.
Rezvani, A., Kholdebarin, E., Brucato, F., Callahan, P., Lowe, D., & Levin, E. (2009) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.018 · Cited by 97
nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives
Parikh, V., Kutlu, M. G., & Gould, T. J. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.020 · Cited by 97
Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers
Mexal, S., Frank, M., Berger, R., Adams, C. E., Ross, R. G., Freedman, R., & Leonard, S. S. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.06.006 · Cited by 93
Self-citation
A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
Shiina, A., Shirayama, Y., Niitsu, T., Hashimoto, T., Yoshida, T., Hasegawa, T., Haraguchi, T., Kanahara, N., Shiraishi, T., Fujisaki, M., et al. (2010) · Annals of General Psychiatry · doi:10.1186/1744-859x-9-27 · Cited by 94
The −2 bp deletion in exon 6 of the ‘alpha 7-like’ nicotinic receptor subunit gene is a risk factor for the P50 sensory gating deficit
Raux, G., Bonnet‐Brilhault, F., Louchart, S., Houy, E., Gantier, R., Levillain, D., Allio, G., Haouzir, S., Petit, M., Martinez, M. M., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001140 · Cited by 93
The Structures of Neuronal Nicotinic Receptors
Lindstrom, J. M. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7_6 · Cited by 91
Nicotinic acetylcholine receptors in neurological and psychiatric diseases
Terry, A. V., Jones, K., & Bertrand, D. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106764 · Cited by 90
Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: Implications for schizophrenia
Pershing, M. L., Bortz, D. M., Pocivavsek, A., Fredericks, P. J., Jørgensen, C. V., Vunck, S. A., Leuner, B., Schwarcz, R. M., & Bruno, J. P. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.017 · Cited by 92
A 2-base pair deletion polymorphism in the partial duplication of the α7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia
Sinkus, M. L., Lee, M. J., Gault, J., Logel, J., Short, M., Freedman, R., Christian, S. L., Lyon, J., & Leonard, S. S. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.041 · Cited by 89
Self-citation
Structure-function of neuronal nicotinic acetylcholine receptor inhibitors derived from natural toxins
Ho, T. N. T., Abraham, N., & Lewis, R. J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.609005 · Cited by 87
Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors
Papke, R. L., & Horenstein, N. A. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000097 · Cited by 92
The effects of nicotine on specific eye tracking measures in schizophrenia
Sherr, J. D., Myers, C. S., Avila, M. T., Elliott, A., Blaxton, T. A., & Thaker, G. K. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01342-2 · Cited by 86
6-[18F]fluoro-A-85380: an in vivo tracer for the nicotinic acetylcholine receptor
Scheffel, U., Horti, A. G., Koren, A. O., Ravert, H. T., Banta, J. P., Finley, P. A., London, E. D., & Dannals, R. F. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(99)00082-7 · Cited by 87
Alzheimer's disease and age-related memory decline (preclinical)
Terry, A. V., Callahan, P. M., Hall, B. J., & Webster, S. J. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.002 · Cited by 86
Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum
Graham, A., COURT, J. A., Martin-Ruiz, C. M., Jaros, E., Perry, R., Volsen, S. G., Bose, S., Evans, N. M., Ince, P. G., Kuryatov, A., et al. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00223-3 · Cited by 85
Acute effect of nicotine on auditory gating in smokers and non-smokers
Harkrider, A. W., & Hedrick, M. S. (2004) · Hearing Research · doi:10.1016/j.heares.2004.11.009 · Cited by 84
Cholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatments
Sarter, M. F., Lustig, C., & Taylor, S. F. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.12.001 · Cited by 82
Comparison of polymorphisms in the α7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects
Gault, J., Hopkins, J. A., Berger, R., Drebing, C. J., Logel, J., Walton, C., Short, M., Vianzon, R., D, A. O. M., Ross, R. G., et al. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20061 · Cited by 83
Self-citation
Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: Implications for drug development
Janhunen, S. K., & Ahtee, L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.09.008 · Cited by 83
PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats
McLean, S. L., Idris, N. F., Grayson, B., Gendle, D. F., Mackie, C. E., Lesage, A. S., Pemberton, D. J., & Neill, J. C. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111431747 · Cited by 81
Targeting alpha-7 nicotinic neurotransmission in schizophrenia: A novel agonist strategy
Deutsch, S. I., Schwartz, B. L., Schooler, N. R., Brown, C. H., Rosse, R. B., & Rosse, S. M. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.05.023 · Cited by 81
Synaptic Dysfunction in Schizophrenia
Yin, D., Chen, Y., Sathyamurthy, A., Xiong, W., & Mei, L. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_22 · Cited by 85
Nicotinic Mechanisms in the Treatment of Psychotic Disorders: A Focus on the α7 Nicotinic Receptor
D, A. O. M., & Freedman, R. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_8 · Cited by 80
Self-citation
Nicotinic acetylcholine receptors: an overview on drug discovery
D’hoedt, D., & Bertrand, D. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902841045 · Cited by 79
Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars
Benes, F. M., Lim, B., Matzilevich, D., Subburaju, S., & Walsh, J. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810153105 · Cited by 78
Preclinical and the first clinical studies on [11C]CHIBA-1001 for mapping α7 nicotinic receptors by positron emission tomography
Toyohara, J., Sakata, M., Wu, J., Ishikawa, M., Oda, K., Ishii, K., Iyo, M., Hashimoto, K., & Ishiwata, K. (2009) · Annals of Nuclear Medicine · doi:10.1007/s12149-009-0240-x · Cited by 84
Alpha-7 nicotinic agonists for cognitive deficits in neuropsychiatric disorders: A translational meta-analysis of rodent and human studies
Lewis, A. S., van Schalkwyk, G. I., & Bloch, M. H. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.01.001 · Cited by 80
Differential effects of cigarette smoking on performance of a smooth pursuit and a saccadic eye movement task in schizophrenia
D, A. O. M., Johnson, L. L., & Ross, R. G. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00022-2 · Cited by 80
Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia
Coyle, J. T., Balu, D. T., Benneyworth, M. A., Basu, A. C., & Roseman, A. S. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.3/jcoyle · Cited by 75
Evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia
Gothelf, D., Soreni, N., Nachman, R., Tyano, S., Hiss, Y., Reiner, O., & Weizman, A. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00097-3 · Cited by 73
Stages of Change in Smokers With Schizophrenia or Schizoaffective Disorder and in the General Population
Etter, M., Mohr, S., Garin, C., & Etter, J. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007092 · Cited by 75
The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review
Girgis, R. R., Zoghbi, A. W., Javitt, D. C., & Lieberman, J. A. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.07.006 · Cited by 75
Targeting α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia
Hajós, M., & Rogers, B. N. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790361434 · Cited by 73
Adjuvant Galantamine Administration Improves Negative Symptoms in a Patient With Treatment-Refractory Schizophrenia
Rosse, R. B., & Deutsch, S. I. (2002) · Clinical Neuropharmacology · doi:10.1097/00002826-200209000-00010 · Cited by 74
Allostatic Load as a Tool for Monitoring Physiological Dysregulations and Comorbidities in Patients with Severe Mental Illnesses
Bízik, G., Picard, M. A., Nijjar, R., Tourjman, V., McEwen, B. S., LUPIEN, S. J., & Juster, R. (2013) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000012 · Cited by 76
Human Brain Imaging of α7 nAChR with [18F]ASEM: a New PET Radiotracer for Neuropsychiatry and Determination of Drug Occupancy
Wong, D. F., Kuwabara, H., Pomper, M. G., Holt, D. P., Brašić, J. R., George, N., Фролов, Б. А., Willis, W. D., Gao, Y., Valentine, H., et al. (2014) · Molecular Imaging and Biology · doi:10.1007/s11307-014-0779-3 · Cited by 74
Cholinergic Axons Modulate GABAergic Signaling among Hippocampal Interneurons via Postsynaptic α7 Nicotinic Receptors
Wanaverbecq, N., Semyanov, A. V., Pavlov, I., Walker, M. C., & Kullmann, D. M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1732-07.2007 · Cited by 74
Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia
Wallace, T. L., & Bertrand, D. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.736498 · Cited by 73
Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors
Hogg, R. C., & Bertrand, D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.010 · Cited by 72
CHRNA7 and CHRFAM7A mRNAs: Co-Localized and Their Expression Levels Altered in the Postmortem Dorsolateral Prefrontal Cortex in Major Psychiatric Disorders
Kunii, Y., Zhang, W., Xu, Q., Hyde, T. M., McFadden, W. C., Shin, J. H., Deep‐Soboslay, A., Ye, T., Li, C., Kleinman, J. E., et al. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14080978 · Cited by 70
Single-Channel and Structural Foundations of Neuronal α7 Acetylcholine Receptor Potentiation
daCosta, C. J. B., Free, C. R., Corradi, J., Bouzat, C., & Sine, S. M. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2652-11.2011 · Cited by 73
Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: A proof-of-mechanism study
Winterer, G., Gallinat, J., Brinkmeyer, J., Musso, F., Kornhuber, J., Thuerauf, N., Rujescu, D., Favis, R., Sun, Y., Franc, M. A., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.040 · Cited by 70
α7 Nicotinic ACh Receptors as a Ligand-Gated Source of Ca2+ Ions: The Search for a Ca2+ Optimum
Uteshev, V. V. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2888-2_27 · Cited by 73
High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia
Dyer, M. A., Freudenreich, O., Maravić, M. C., Pachas, G. N., Deckersbach, T., MURPHY, E., GOFF, D. C., & Evins, A. E. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.12.491 · Cited by 70
Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial
Smith, R. C., Amiaz, R., Si, T., Maayan, L. A., Jin, H., Boules, S., Sershen, H. W., Li, C., Ren, J., Liu, Y., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0143490 · Cited by 83
Nicotine reduces antisaccade errors in task impaired schizophrenic subjects
Larrison, A. L., MATORIN, A. A., & Sereno, A. B. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.01.002 · Cited by 69

Authors: Freedman, R., Hall, M., Adler, L. E., & Leonard, S.
Affiliations: Denver VA Medical Center (US)
University of Colorado Denver (US)
Corresponding author: Freedman, Robert
ORCID: Freedman, Robert
Hall, Michael
Venue: Biological Psychiatry
Publisher: Elsevier BV
Published: 1995-07
Volume: 38
Issue: 1
Pages: 22-33
ISSN: 0006-3223 (ISSN-L)
DOI: 10.1016/0006-3223(94)00252-x
OpenAlex: W2090019512
Cited by: 678
References: 55
Citations by year: 2026: 2 · 2025: 10 · 2024: 8 · 2023: 12 · 2022: 11 · 2021: 16 · 2020: 18 · 2019: 17 · 2018: 11 · 2017: 17 · 2016: 18 · 2015: 34 · 2014: 29 · 2013: 27 · 2012: 30
FWCI: 3.72
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Biological Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (1k01mh000728-01a1)
National Institute of Mental Health (MH-44212, MH00728, MH 38321, P50MH044212)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: schizophrenia, nicotinic acetylcholine receptors, hippocampus, alpha-bungarotoxin binding, auditory gating, inhibitory interneurons, dentate gyrus, CA3 region, postmortem brain, cholinergic dysfunction
MeSH terms: Quinolizidine Alkaloids, Adult, Aged, Alkaloids, Autoradiography, Azocines, Binding Sites, Bungarotoxins, Cell Count, Female, Hippocampus, Humans, Image Processing, Computer-Assisted, Male, Middle Aged, Quinolizines, Receptors, Nicotinic, Schizophrenia, Cholinergic Agents, Dentate Gyrus, Culture Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks